HAMAD MEDICAL CORPORATION
🇶🇦Qatar
Qatar PREgnancy Covid-19 OUtcome Study
- Conditions
- Pregnant WomenCOVID-19
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 4000
- Registration Number
- NCT05349279
- Locations
- 🇶🇦
Women's Wellness and Research Center, Doha, Qatar
Automated Inferior Vena Cava Collapsibility Index Fluid Responsiveness in Ventilated Patients After Cardiac Surgery.
- Conditions
- ICUHemodynamic MonitoringCardiac Surgery
- Interventions
- Diagnostic Test: Automated echocardiographic inferior vena cava measurement
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT05283590
- Locations
- 🇶🇦
Hamad medical corporation, Doha, Qatar
COVID-19 Among Children With Chronic Renal Diseases in Qatar
Completed
- Conditions
- COVID-19 InfectionCOVID-19 PandemicAcute Kidney InjuryChronic Renal Failure in ChildrenChronic Kidney Diseases
- Interventions
- Other: Medical records review
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 1300
- Registration Number
- NCT05275595
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Appropriateness of Carpal Tunnel Syndrome Management Compared With the AAOS Appropriate Use Criteria
- Conditions
- Carpal Tunnel Syndrome
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 136
- Registration Number
- NCT05275816
Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT05165992
Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.
- First Posted Date
- 2021-11-12
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT05118737
- Locations
- 🇶🇦
Alaa Rahal, Doha, DA, Qatar
CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
Phase 4
Withdrawn
- Conditions
- Hematologic CancerNeutropenia, Febrile
- Interventions
- Drug: Ceftolozane-tazobactam IV
- First Posted Date
- 2021-09-29
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Hamad Medical Corporation
- Registration Number
- NCT05061654
- Locations
- 🇶🇦
Hamad Medical Corporation, National Center for Cancer Care and Research, Doha, Qatar
Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO
Completed
- Conditions
- COVID-19 PneumoniaExtracorporeal Membrane Oxygenation ComplicationTracheostomy ComplicationRespiratory Failure
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT05045885
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Evaluation of Preoperative Nasoendoscopy to Predict Difficult Intubation
Not Applicable
- Conditions
- Difficult or Failed IntubationObesity, Morbid
- Interventions
- Procedure: Awake Airway Nasoendoscopy
- First Posted Date
- 2021-09-14
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT05043779
- Locations
- 🇶🇦
ACC, Hamad Medical Corporation, Doha, Doah, Qatar
Effect of Human Plasma Protein Transfusion With and Without Crystalloids During Major Liver Resection Surgeries
Not Applicable
- Conditions
- Fluid Electrolyte DisordersCoagulation; Intravascular
- Interventions
- Drug: 5% human plasma protein fraction (PPF)
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT05033704
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Ad Dawhah, Qatar
© Copyright 2025. All Rights Reserved by MedPath